Griseofulvin

• Post Date:

  Mar 15,2013

• Expiry Date:

  Sep 11,2013

• Detailed Description:

  Cas No. :126-07-8 Griseofulvin
  Product name: Griseofulvin
  Other name: grisovin;(+)-Griseofulvin
  CAS No.: 126-07-8
  Assay: 97.0%-102.0%
  Packing: 20kg/drum
  M.F.: C17H19ClO6
  M.W.: 354.7822
  Reference standard: BP2005/EP5/CP2010
  Appearance: White or white crystalline powder
  
  
  Griseofulvin (marketed under the proprietary name Grifulvin V by Orthoneutrogena Labs, according to FDA orange book) is an antifungal drug that is administered orally. It is used both in animals and in humans, to treat fungal infections of the skin (commonly known as ringworm) and nails. It is produced by culture of some strains of the mold Penicillium griseofulvum, from which it was isolated in 1939.
  
  
  Uses
  
  Griseofulvin is used orally only for dermatophytosis. It is ineffective topically. Griseofulvin is reserved for cases with nail, hair or large body surface involvement.
  

• CAS Registry Number:

  126-07-8

• Synonyms:

  ;grisovin;7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione;(2S,6'R)-7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione;(2R,6'S)-7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione;(2S,6'S)-7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione;(2S,6'R)-7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohexane]-3,4'-dione;Spiro[benzofuran-2(3H),1'-[2]cyclohexene]-3,4'-dione,7-chloro-2',4,6-trimethoxy-6'-methyl-, (1'R-trans)-;(+)-Griseofulvin;

• Molecular Formula:

  C₁₇H₁₉ClO₆

• Molecular Weight:

  354.7822

• Molecular Structure:

  

• Hazard Symbols:

   T:Toxic;
  

• Risk Codes:

  R60:;
  R61:;
  R40:;
  R43:;
  

• Safety Description:

  S53:;
  S22:;
  S36/37/39:;
  S45:;
  

• Company:

  Hubei Yuancheng pharmaceutical Co.,Ltd     [ China ]        

• Contact:

  Harry

• Tel:

  86-27-88082236

• Fax:

• Email:

  ycgsales03@ycphar.com